BPaL regimen Current Affairs, GK & News
PRETOMANID: US FDA approves new drug for drug-resistant TB
United States (US) Food and Drug Administration (FDA) has approved new drug-Pretomanid for treating drug-resistant strain of Tuberculosis (TB). Pretomanid is novel compound developed by New York-based non-profit organisation TB Alliance. It is used alongside two other antibiotics (bedaquiline and linezolid) to treat extremely drug-resistant strain of tuberculosis. This three-drug regimen is collectively known as ..
Month: Current Affairs - August, 2019
Category: Science & Technology Current Affairs
Topics: Bedaquiline • BPaL regimen • Diseases • Drug resistant TB • Linezolid • Pretomanid • Public health • TB Alliance • US FDA